Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.

Rönkkö R, Juutilainen A, Koivula I, Vänskä M, Nousiainen T, Jantunen E, Hämäläinen S.

Infect Dis (Lond). 2018 Jun;50(6):436-442. doi: 10.1080/23744235.2017.1420221. Epub 2018 Jan 5.

PMID:
29303041
2.

Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly.

Partanen A, Valtola J, Ropponen A, Vasala K, Penttilä K, Ågren L, Pyörälä M, Nousiainen T, Selander T, Mäntymaa P, Pelkonen J, Varmavuo V, Jantunen E.

Ann Hematol. 2017 Nov;96(11):1897-1906. doi: 10.1007/s00277-017-3123-6. Epub 2017 Sep 7.

PMID:
28879595
3.

Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.

Luukkonen J, Pascual LM, Patlaka C, Lång P, Turunen S, Halleen J, Nousiainen T, Valkealahti M, Tuukkanen J, Andersson G, Lehenkari P.

PLoS One. 2017 Aug 8;12(8):e0182904. doi: 10.1371/journal.pone.0182904. eCollection 2017.

4.

Bloodstream infections in acute myeloid leukemia patients treated according to the Finnish Leukemia Group AML-2003 protocol - a prospective nationwide study.

Kolonen A, Sinisalo M, Huttunen R, Syrjänen J, Aittoniemi J, Huhtala H, Sankelo M, Rintala H, Räty R, Jantunen E, Nousiainen T, Säily M, Kauppila M, Itälä-Remes M, Ollikainen H, Rauhala A, Koistinen P, Elonen E; Finnish Leukemia Group.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):799-808. doi: 10.1080/23744235.2017.1347814. Epub 2017 Jul 6.

PMID:
28683646
5.

Cytokine data obtained from synovial stromal cells of patients with rheumatoid arthritis or osteoarthritis.

Huhtakangas JA, Veijola J, Turunen S, Karjalainen A, Valkealahti M, Nousiainen T, Yli-Luukko S, Vuolteenaho O, Lehenkari P.

Data Brief. 2017 Apr 29;12:593-602. doi: 10.1016/j.dib.2017.04.041. eCollection 2017 Jun.

6.

Poor Acetabular Component Orientation Increases Revision Risk in Metal-on-Metal Hip Arthroplasty.

Tauriainen TJT, Niinimäki TT, Niinimäki JL, Nousiainen TOP, Leppilahti JI.

J Arthroplasty. 2017 Jul;32(7):2204-2207. doi: 10.1016/j.arth.2017.02.009. Epub 2017 Feb 14.

PMID:
28291650
7.

Old enemies in new disguises: emergence of Enterococcus faecium as a significant clinical problem at an adult haematology ward.

Hämäläinen S, Pentikäinen J, Reijula J, Mauranen E, Koivula I, Lindholm L, Juutilainen A, Nousiainen T, Pyörälä M, Vuopio J, Jantunen E.

Infect Dis (Lond). 2017 Aug;49(8):628-631. doi: 10.1080/23744235.2017.1296969. Epub 2017 Mar 3. No abstract available.

PMID:
28276797
8.

Pre-emptive plerixafor injection in lymphoma patients mobilized with chemotherapy plus pegfilgrastim followed by apheresis on the same day.

Jantunen E, Partanen A, Valtola J, Pyörälä M, Mäntymaa P, Nousiainen T, Varmavuo V.

J Clin Apher. 2017 Dec;32(6):594-596. doi: 10.1002/jca.21522. Epub 2017 Feb 7. No abstract available.

PMID:
28171695
9.

1,25(OH)2D3 and calcipotriol, its hypocalcemic analog, exert a long-lasting anti-inflammatory and anti-proliferative effect in synoviocytes cultured from patients with rheumatoid arthritis and osteoarthritis.

Huhtakangas JA, Veijola J, Turunen S, Karjalainen A, Valkealahti M, Nousiainen T, Yli-Luukko S, Vuolteenaho O, Lehenkari P.

J Steroid Biochem Mol Biol. 2017 Oct;173:13-22. doi: 10.1016/j.jsbmb.2017.01.017. Epub 2017 Feb 3.

PMID:
28167299
10.

Modeling the scattering phase matrix of red clays.

Jin C, Liu C, Yin Y, Bi L, Nousiainen T.

Opt Lett. 2016 Nov 1;41(21):4879-4882. doi: 10.1364/OL.41.004879.

PMID:
27805640
11.

Rheumatoid arthritis antigens homocitrulline and citrulline are generated by local myeloperoxidase and peptidyl arginine deiminases 2, 3 and 4 in rheumatoid nodule and synovial tissue.

Turunen S, Huhtakangas J, Nousiainen T, Valkealahti M, Melkko J, Risteli J, Lehenkari P.

Arthritis Res Ther. 2016 Oct 20;18(1):239.

12.

Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).

Kuitunen H, Tokola S, Siniluoto T, Isokangas M, Sonkajärvi E, Alahuhta S, Turpeenniemi-Hujanen T, Jantunen E, Nousiainen T, Vasala K, Kuittinen O.

J Neurooncol. 2017 Jan;131(2):293-300. doi: 10.1007/s11060-016-2293-8. Epub 2016 Oct 17.

PMID:
27752883
13.

Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance.

Valtola J, Varmavuo V, Ropponen A, Selander T, Kuittinen O, Kuitunen H, Keskinen L, Vasala K, Nousiainen T, Mäntymaa P, Pelkonen J, Jantunen E.

Leuk Lymphoma. 2016 Sep;57(9):2025-32. doi: 10.3109/10428194.2015.1129537. Epub 2016 Jan 14.

PMID:
26763346
14.

Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison.

Valtola J, Varmavuo V, Ropponen A, Nihtinen A, Partanen A, Vasala K, Lehtonen P, Penttilä K, Pyörälä M, Kuittinen T, Silvennoinen R, Nousiainen T, Pelkonen J, Mäntymaa P, Jantunen E.

Transfusion. 2015 Oct;55(10):2358-68. doi: 10.1111/trf.13170. Epub 2015 May 28.

PMID:
26018461
15.

Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study.

Harjama L, Kuitunen H, Turpeenniemi-Hujanen T, Haapasaari KM, Leppä S, Mannisto S, Karjalainen-Lindsberg ML, Lehtinen T, Eray M, Vornanen M, Haapasalo H, Soini Y, Jantunen E, Nousiainen T, Vasala K, Kuittinen O.

Acta Oncol. 2015 Jun;54(6):939-43. doi: 10.3109/0284186X.2014.990110. Epub 2015 Mar 11.

PMID:
25761092
16.

Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients.

Varmavuo V, Rimpiläinen J, Kuitunen H, Nihtinen A, Vasala K, Mikkola M, Kutila A, Lehtonen P, Kuittinen T, Mäntymaa P, Nousiainen T, Kuittinen O, Jantunen E.

Transfusion. 2014 May;54(5):1243-50. doi: 10.1111/trf.12434. Epub 2013 Sep 30.

PMID:
24118008
17.

Light scattering by the Martian dust analog, palagonite, modeled with ellipsoids.

Merikallio S, Nousiainen T, Kahnert M, Harri AM.

Opt Express. 2013 Jul 29;21(15):17972-85. doi: 10.1364/OE.21.017972.

PMID:
23938669
18.

Models for integrated and differential scattering optical properties of encapsulated light absorbing carbon aggregates.

Kahnert M, Nousiainen T, Lindqvist H.

Opt Express. 2013 Apr 8;21(7):7974-93. doi: 10.1364/OE.21.007974.

PMID:
23571889
19.

CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients.

Varmavuo V, Mäntymaa P, Silvennoinen R, Nousiainen T, Kuittinen T, Jantunen E.

Transfusion. 2013 May;53(5):1024-32. doi: 10.1111/j.1537-2995.2012.03848.x. Epub 2012 Aug 15.

PMID:
22897584
20.

Effect of the orientation of the optic axis on simulated scattering matrix elements of small birefringent particles.

Dabrowska DD, Muñoz O, Moreno F, Nousiainen T, Zubko E.

Opt Lett. 2012 Aug 1;37(15):3252-4. doi: 10.1364/OL.37.003252.

PMID:
22859149
21.

Plasma copeptin in the assessment of febrile neutropenia.

Purhonen AK, Vänskä M, Hämäläinen S, Pulkki K, Lehtikangas M, Kuittinen T, Nousiainen T, Koivula I, Jantunen E, Juutilainen A.

Peptides. 2012 Jul;36(1):129-32. doi: 10.1016/j.peptides.2012.05.001. Epub 2012 May 11.

PMID:
22580173
22.

Blood graft composition after plerixafor injection in patients with NHL.

Varmavuo V, Mäntymaa P, Nousiainen T, Valonen P, Kuittinen T, Jantunen E.

Eur J Haematol. 2012 Aug;89(2):128-35. doi: 10.1111/j.1600-0609.2012.01794.x. Epub 2012 May 24.

PMID:
22536949
23.

Optical properties of light absorbing carbon aggregates mixed with sulfate: assessment of different model geometries for climate forcing calculations.

Kahnert M, Nousiainen T, Lindqvist H, Ebert M.

Opt Express. 2012 Apr 23;20(9):10042-58. doi: 10.1364/OE.20.010042.

PMID:
22535095
24.
25.

Economic evaluation of sequential treatments for follicular non-hodgkin lymphoma.

Soini EJ, Martikainen JA, Vihervaara V, Mustonen K, Nousiainen T.

Clin Ther. 2012 Apr;34(4):915-925.e2. doi: 10.1016/j.clinthera.2012.02.019. Epub 2012 Mar 27.

PMID:
22459623
26.

Blood graft lymphocyte subsets after plerixafor injection in non-Hodgkin's lymphoma patients mobilizing poorly with chemotherapy plus granulocyte-colony-stimulating factor.

Varmavuo V, Mäntymaa P, Kuittinen T, Nousiainen T, Jantunen E.

Transfusion. 2012 Aug;52(8):1785-91. doi: 10.1111/j.1537-2995.2011.03525.x. Epub 2012 Feb 5.

PMID:
22304442
27.

Kinetics of blood CD34(+) cells after chemotherapy plus G-CSF in poor mobilizers: implications for pre-emptive plerixafor use.

Jantunen E, Varmavuo V, Juutilainen A, Kuittinen T, Mahlamäki E, Mäntymaa P, Nousiainen T.

Ann Hematol. 2012 Jul;91(7):1073-9. doi: 10.1007/s00277-012-1411-8.

PMID:
22302373
28.

Comparative evaluation of autohydrolysis and acid-catalyzed hydrolysis of Eucalyptus globulus wood.

Gütsch JS, Nousiainen T, Sixta H.

Bioresour Technol. 2012 Apr;109:77-85. doi: 10.1016/j.biortech.2012.01.018. Epub 2012 Jan 15.

PMID:
22297049
29.

A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy.

Sipola P, Vanninen E, Jantunen E, Nousiainen T, Kiviniemi M, Hartikainen J, Kuittinen T.

Nucl Med Commun. 2012 Jan;33(1):51-9. doi: 10.1097/MNM.0b013e32834bfec4. Erratum in: Nucl Med Commun. 2013 Jul;34(7):726. Petri, Sipola [corrected to Sipola, Petri]; Esko, Vanninen [corrected to Vanninen, Esko]; Esa, Jantunen [corrected to Jantunen, Esa]; Tapio, Nousiainen [corrected to Nousiainen, Tapio]; Mikko, Kiviniemi [corrected to Kiviniemi, Mikko]; Juha, Hartikainen [c.

PMID:
22044862
30.

High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.

Vänskä M, Koivula I, Hämäläinen S, Pulkki K, Nousiainen T, Jantunen E, Juutilainen A.

Haematologica. 2011 Sep;96(9):1385-9. doi: 10.3324/haematol.2011.044925.

31.

Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis.

Juutilainen A, Hämäläinen S, Pulkki K, Kuittinen T, Nousiainen T, Jantunen E, Koivula I.

Leuk Lymphoma. 2011 Dec;52(12):2349-55. doi: 10.3109/10428194.2011.597904. Epub 2011 Jul 14.

PMID:
21756036
32.

Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy.

Juutilainen A, Vänskä M, Pulkki K, Hämäläinen S, Nousiainen T, Jantunen E, Koivula I.

Eur J Haematol. 2011 Nov;87(5):441-7. doi: 10.1111/j.1600-0609.2011.01666.x. Epub 2011 Aug 15.

PMID:
21676033
33.

Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.

Koivula I, Hämäläinen S, Jantunen E, Pulkki K, Kuittinen T, Nousiainen T, Juutilainen A.

Scand J Infect Dis. 2011 Jul;43(6-7):471-8. doi: 10.3109/00365548.2011.554855. Epub 2011 Feb 7.

PMID:
21299364
34.

Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience.

Jantunen E, Kuittinen T, Mahlamäki E, Pyörälä M, Mäntymaa P, Nousiainen T.

Eur J Haematol. 2011 Apr;86(4):299-304. doi: 10.1111/j.1600-0609.2010.01573.x. Epub 2011 Jan 31.

PMID:
21198864
35.

Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up.

Soini EJ, Martikainen JA, Nousiainen T.

Ann Oncol. 2011 May;22(5):1189-97. doi: 10.1093/annonc/mdq582. Epub 2010 Dec 6.

36.

Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters.

Syrjälä H, Ohtonen P, Kinnunen U, Räty R, Elonen E, Nousiainen T, Jantunen E, Remes K, Itälä-Remes M, Silvennoinen R, Koistinen P; Finnish Leukemia Group.

Eur J Clin Microbiol Infect Dis. 2010 Oct;29(10):1211-8. doi: 10.1007/s10096-010-0984-1. Epub 2010 Jun 17.

PMID:
20556469
37.

Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein.

Hämäläinen S, Juutilainen A, Kuittinen T, Nousiainen T, Matinlauri I, Pulkki K, Koivula I, Jantunen E.

Leuk Lymphoma. 2010 Jun;51(6):1040-6. doi: 10.3109/10428191003743478.

PMID:
20470220
38.

Addition of plerixafor to a chemotherapy plus G-CSF mobilization in hard-to-mobilize patients.

Jantunen E, Penttilä K, Pyörälä M, Mahlamäki E, Kuittinen T, Nousiainen T.

Bone Marrow Transplant. 2011 Feb;46(2):308-9. doi: 10.1038/bmt.2010.93. Epub 2010 Apr 19. No abstract available.

PMID:
20400986
39.

Validity criteria of the discrete dipole approximation.

Zubko E, Petrov D, Grynko Y, Shkuratov Y, Okamoto H, Muinonen K, Nousiainen T, Kimura H, Yamamoto T, Videen G.

Appl Opt. 2010 Mar 10;49(8):1267-79. doi: 10.1364/AO.49.001267.

PMID:
20220882
40.

Late potentials and QT dispersion after high-dose chemotherapy in patients with non-Hodgkin lymphoma.

Kuittinen T, Jantunen E, Vanninen E, Mussalo H, Nousiainen T, Hartikainen J.

Clin Physiol Funct Imaging. 2010 May;30(3):175-80. doi: 10.1111/j.1475-097X.2009.00920.x. Epub 2010 Jan 28.

PMID:
20132128
41.

Serial plasma lactate measurements in haematological patients with neutropenic fever.

Juutilainen A, Hämäläinen S, Matinlauri I, Kuittinen T, Nousiainen T, Pulkki K, Koivula I, Jantunen E.

Scand J Infect Dis. 2010;42(2):102-8. doi: 10.3109/00365540903338113.

PMID:
19883163
42.

Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome.

Hamalainen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E.

Scand J Infect Dis. 2009;41(1):14-20. doi: 10.1080/00365540802454706.

PMID:
18836947
43.

Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.

Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E.

Leuk Lymphoma. 2008 Mar;49(3):495-501. doi: 10.1080/10428190701809172.

PMID:
18297526
44.

Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.

Jantunen E, Itälä M, Siitonen T, Kuittinen T, Heiskanen J, Koivunen E, Juvonen E, Silvennoinen R, Nousiainen T, Koistinen P, Volin L, Remes K.

Bone Marrow Transplant. 2008 Feb;41(3):239-44. Epub 2007 Oct 29.

PMID:
17968327
45.

Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.

Koistinen P, Räty R, Itälä M, Jantunen E, Koivunen E, Nousiainen T, Pelliniemi TT, Remes K, Ruutu T, Savolainen ER, Siitonen T, Silvennoinen R, Volin L, Elonen E; Finnish Leukaemia Group.

Eur J Haematol. 2007 Jun;78(6):477-86. Epub 2007 Mar 28.

PMID:
17391337
46.

Secondary acute promyelocytic leukemia: an increasingly common entity.

Jantunen E, Heinonen K, Mahlamäki E, Penttilä K, Kuittinen T, Lehtonen P, Pyörälä M, Hänninen A, Nousiainen T.

Leuk Lymphoma. 2007 Jan;48(1):190-1. No abstract available.

PMID:
17325866
47.

Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.

Kuittinen T, Jantunen E, Vanninen E, Mussalo H, Vuolteenaho O, Ala-Kopsala M, Nousiainen T, Hartikainen J.

Eur J Haematol. 2006 Aug;77(2):120-7.

PMID:
16856907
48.

Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003.

Jantunen E, Itälä M, Siitonen T, Koivunen E, Leppä S, Juvonen E, Kuittinen O, Lehtinen T, Koistinen P, Nyman H, Nousiainen T, Volin L, Remes K.

Eur J Haematol. 2006 Aug;77(2):114-9.

PMID:
16856906
49.

Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience.

Jantunen E, Itälä M, Siitonen T, Juvonen E, Koivunen E, Koistinen P, Volin L, Remes K, Nousiainen T.

Bone Marrow Transplant. 2006 Jun;37(12):1093-8. Epub 2006 May 8.

PMID:
16699533
50.

Supplemental Content

Loading ...
Support Center